All the news Showing 10 of 135 articles from: Interferon-free regimensGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources FDA OK's BMS Daklinza (Daclatasvir) to Treat Hep C Genotype 3 Manual Items / 27 July 2015 FDA approves Technivie for treatment of chronic hepatitis C genotype 4 FDA / 27 July 2015 AbbVie Announces New Phase 3b Results in Genotype 1b Chronic Hepatitis C Patients with Compensated Liver Cirrhosis AbbVie press release / 24 June 2015 Pricing remains main barrier to HCV eradication Digestive Disease Week News / 20 May 2015 Merck and Gilead square off in battle of the next-next-gen hep C combos Fierce Biotech / 24 April 2015 Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie The Street / 09 April 2015 Bristol-Myers Squibb Co. Is Back in the Hepatitis C Race Motley Fool / 18 March 2015 Gilead's hepatitis C drugs largely cost-effective in US - study Reuters / 17 March 2015 NICE consults on draft guidance recommending ledipasvir-sofosbuvir (Harvoni) for treating chronic hepatitis C NICE / 04 March 2015 Gilead's Harvoni gains NICE yes - but won't face funding delay PM Live / 03 March 2015 ← Prev12345...14Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive